Tumor Ablation Techniques

Ablation Fundamentals - Zap & Control

• Goal: Localized tumor destruction via chemical or thermal energy.
• Intent: Curative, palliative, or bridge to transplant.
• Mechanisms:
  • Thermal: Heat (RFA, MWA, Laser, HIFU); Cold (Cryoablation).
  • Chemical: Ethanol, Acetic Acid.
  • Non-thermal: Irreversible Electroporation (IRE).
• Key Factors: Tumor size/location, proximity to vital structures.
• Ablation Zone: Tumor + 0.5-1 cm safety margin.
• Guidance: Ultrasound (US), CT, MRI.

⭐ Ablation is a key treatment for non-surgical candidates with early-stage HCC (e.g., BCLC Stage 0/A).

Thermal Ablation - Heat vs. Cold

Thermal ablation uses extreme temperatures for tumor destruction. Heat-based: RFA, MWA. Cold-based: Cryoablation.

• Mechanisms:
  • RFA: Frictional heat ($\textbf{60-100}$°C).
  • MWA: Dielectric heat ($> \textbf{100}$°C).

    ⭐ MWA is less susceptible to 'heat sink' effect vs RFA; better for perivascular tumors.

  • Cryoablation: Joule-Thomson effect, ice ball ($< \textbf{-40}$°C).

Comparative Overview:

Non-Thermal & Chemical - Shock & Dissolve

• Irreversible Electroporation (IRE)
  • Mechanism: High-voltage, short electrical pulses create nanopores in cell membranes → apoptosis.
  • Non-thermal; spares extracellular matrix, vessels, ducts.

  ⭐ Irreversible Electroporation (IRE) is a non-thermal technique that preserves surrounding connective tissue matrix, making it suitable near delicate structures like bile ducts or major vessels.

• Chemical Ablation
  • Agents: Ethanol (95-100%), Acetic Acid.
  • Mechanism: Cellular dehydration, protein denaturation, tumor necrosis.
  • Used for: Hepatocellular carcinoma (HCC), thyroid cysts, venous malformations.

and Chemical Ablation techniques in tumor treatment)

Procedural Blueprint - Plan, Guide, Follow

• Plan:
  • Pre-procedural imaging (CT/MRI/US): tumor characterization, localization, access planning.
  • Select ablation modality (e.g., RFA, MWA), anesthesia.
• Guide:
  • Imaging Guidance:
    • US: Real-time, no radiation, portable.
    • CT: Excellent spatial resolution, deep lesions.
    • MRI: Superior soft tissue contrast, no radiation.
  • Accurate probe placement is critical.
• Follow:
  • Post-ablation imaging: Contrast CT/MRI at 1 month, then 3-6 monthly.
  • Assess treatment response; monitor complications.

⭐ Post-ablation success is typically defined by complete lack of enhancement in the treated zone on contrast-enhanced CT/MRI at 1-month follow-up.

Ablation Aftermath - Risks & Fixes

• Common:
  • Pain: Analgesics.
  • Bleeding: Monitor; embolization if severe.
  • Infection/Abscess: Antibiotics, drainage.
• Specific Risks:
  • Pneumothorax (lung/liver): Chest tube.
  • Non-target injury (nerve, bowel): Supportive/surgical.
  • Skin burns (RF/MW): Prevention crucial.
  • Tract seeding (rare): Tract ablation.

⭐ Post-ablation syndrome (fever, malaise, myalgia, leukocytosis) is a common, self-limiting systemic inflammatory response, not necessarily infection.

High‑Yield Points - ⚡ Biggest Takeaways

• Radiofrequency Ablation (RFA): Most common thermal ablation for small tumors (<3 cm), e.g., HCC.
• Microwave Ablation (MWA): Larger ablation zones, less heat sink effect, good near vessels.
• Cryoablation: Freezes tumors ("ice ball"), good for pain palliation (bone mets), renal tumors.
• Irreversible Electroporation (IRE): Non-thermal, spares vessels/ducts, used for pancreatic/hilar tumors.
• Ethanol (PEI): Chemical ablation for cystic lesions, small HCCs.
• Image guidance (US/CT) is crucial for precise targeting and safety.
• Key risks: Pain, bleeding, non-target ablation, post-ablation syndrome.